HUC3-637

N/A

Report date: 2026/03/16 20:01:47
NME

Base Information

Drug NameHUC3-637
Drug Alias NameHUC3-637
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCarbonic anhydrases inhibitorsBeta adrenergic receptors antagonists
TargetsCarbonic anhydrasesBeta adrenergic receptors
Therapy Area/IndicationsGlaucoma, Open-AngleOcular Hypertension
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsYes Dorzolamide HydrochlorideTimolol
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesHuons Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesHuons Co Ltd
Inactive CompaniesN/A
Active IndicationsGlaucoma, Open-AngleOcular Hypertension
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A